Recent News and Updates
Wilson Disease Reviewed in Top Medical Journal
The Wilson Disease Association (WDA) is excited to share that the review article, “Current and Emerging Issues in Wilson’s Disease,” by Dr. Eve Roberts and Dr. Michael Schilsky is published in this week’s New [...]
Ultragenyx Wilson Disease Update August 2023
On behalf of the Ultragenyx Wilson disease study team, we would like to share an update on our CYPRUS2+ study. […]
How Mark Cuban helped a Cherry Hill business exec cut prices for the drug that keeps him alive
For decades, the drug that keeps Drew Katz alive sold for less than $1 a pill. […]
WD Low Cost Drugs
Read the press release.
Alexion’s Wilson Disease Drug Program Terminated
April 28, 2023 The Wilson Disease Association (WDA) is disappointed to share that Alexion, AstraZeneca Rare Disease decided to terminate its ALXN1840 program. Alexion pursued rigorous scientific research in its effort to bring forward a [...]
New Drug Launched
Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease. Read the press release.


